XML 49 R28.htm IDEA: XBRL DOCUMENT v3.6.0.2
Business Combination (Tables)
12 Months Ended
Dec. 31, 2016
Business Combinations [Abstract]  
Summary of purchase price allocation
Cash and cash equivalents
 
$
136

Prepaid expenses and other assets
 
1,162

Property and equipment
 
867

In-process research and development - U.S. Vicinium
 
12,200

In-process research and development - E.U. Vicinium
 
41,100

In-process research and development - R.O.W. Vicinium
 
7,200

Goodwill
 
16,864

Accounts payable
 
(1,163
)
Accrued expenses
 
(1,494
)
Other liabilities
 
(812
)
Deferred tax liability
 
(16,335
)
 
 
$
59,725

Schedule of previously reported fair values and currently reported fair value
The previously reported fair values and the currently reported fair values as of the Acquisition Date, including Contingent Consideration, are reflected in the following table (in thousands):
 
 
Previously Reported
 
Currently Reported
In-process research and development - Vicinium
 
$
35,400

 
$

In-process research and development - U.S. Vicinium
 
$

 
$
12,200

In-process research and development - E.U. Vicinium
 
$

 
$
41,100

In-process research and development - R.O.W. Vicinium
 
$

 
$
7,200

In-process research and development - Proxinium
 
$
800

 
$

Goodwill
 
$
10,312

 
$
16,864

Deferred tax liability
 
$
(9,774
)
 
$
(16,335
)
Contingent Consideration
 
$
(21,900
)
 
$
(46,200
)
Summary of pro forma financial information
The unaudited estimated pro forma results presented below include the effects of the Acquisition as if it had been consummated as of the beginning of each period. The pro forma results include the direct expenses of Viventia as well as the additional depreciation expense as a result of the increase in the fair value of the fixed assets. The pro forma results exclude the costs of the transaction, severance and stock-based compensation expenses, the Viventia forgiveness of debt and the related interest expense in connection with the Acquisition. In addition, the pro forma results do not include any anticipated synergies or other expected benefits of the Acquisition. Accordingly, the unaudited estimated pro forma financial information below is not necessarily indicative of either future results of operations or results that might have been achieved had the Acquisition been consummated as of the beginning of each period (in thousands):
 
Year Ended December 31,
 
2016
 
2015
Revenue
$
29,981

 
$
990

Net loss
(3,026
)
 
(47,483
)